05.05.2014
- U.S. drugmaker Pfizer increased its offer for the UK's AstraZeneca on May 2 to £63 billion ($106 billion) but the proposal, which would create the world's biggest pharmaceuticals...
29.04.2014
- Pfizer is now expected to increase its $100 billion offer to acquire UK rival AstraZeneca after being rebuffed a second time. The company has confirmed that it approached its...
29.04.2014
- Generics producer Actavis has sued the U.S. Food and Drug Administration, challenging its decision to award exclusive rights to Israel's Teva to sell a generic version of Pfizer's...
28.04.2014
- Germany's Bayer and British consumer products giant Reckitt are said to have emerged as frontrunners to win the auction for the Merck & Co consumer products unit, each reportedly...
25.04.2014
- AstraZeneca has unveiled plans to sell or partner infection and neuroscience units with combined 2013 sales of $3.5 billion and a basis in antibiotics and antipsychotics as well as...
23.04.2014
- In reports that emerged at Easter, U.S. pharmaceutical giant Pfizer is said to have held informal talks with AstraZeneca about buying the London-based maker of asthma and heart...
23.04.2014
- In one of several deals announced just after Easter, Swiss drugmaker Novartis said it would sell its animal health arm to U.S. rival Eli Lilly for about $5.4 billion. Lilly said...
23.04.2014
- Novartis and GlaxoSmithKline have announced an asset swap worth more than $20 billion, with an eye to bolstering their best businesses and exiting weaker ones. The swap, which...
